Takeda
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PANTPAS gastro-resistant tablet 40 mg
- PANTPAS lyophilisate for solution for injection 40 mg
- A10 - Antidiabéticos
- ACTOS tablet 15 mg
- ACTOS tablet 30 mg
- VIPIDIA film-coated tablet 25 mg
- L01 - Antineoplásicos
- ADCETRIS concentrate for solution for infusion 50 mg
- L03 - Inmunoestimulantes
- BCG SSI KULTURU powder for suspension for injection
- MEPACT CONCENTRATE SOLUTION powder for solution for infusion 4 mg
- M01 - Antiinflamatorios y antirreumáticos
- DURAPROX film-coated tablet 600 mg
- XEFO RAPID film-coated tablet 8 mg
- R01 - Preparaciones nasales
- OMNARIS nasal spray, solution 50 µg/dose
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- AIRPLUS DISCAIR inhalation powder 50 µg+100 µg
- AIRPLUS DISCAIR inhalation powder 50 µg+250 µg
- AIRPLUS pressurised inhalation, suspension 25 µg/dose+125 µg/dose
- AIRPLUS pressurised inhalation, suspension 25 µg/dose+250 µg/dose
- ALVESCO pressurised inhalation, solution 160 µg/dose
- ALVESCO pressurised inhalation, solution 80 µg/dose